Pharm Flashcards
Ondansetron (zofran)
Anti-emetic - acute
MOA: bind serotonin receptors in GI tract
Tox: Headache, hiccups, QT long, constipation
Aprepitant (Emend)
Anti-emetic - delayed
MOA: NK1 receptor antagonist (central and peripheral action)
Tox: drug interaction, hiccups, fatigue
Prochlorperazine (compazine)
Anti-emetic - delayed
MOA: bind dopamine D1/D2 receptors in chemoreceptor trigger zone
Tox: extrapyramidal side effects, sedation
Dexamethasone (Decadron)
corticosteroid used for anti-emetic properties
MOA: unknown
Tox: glucose intolerance, insomnia, agitation
Lorazepam (Ativan)
benzo used for anit-emetic properties
MOA: limbic, thalamic and hypothalamic areas via GABA
Tox: sedation, retrograde amnesia
Metoclorpramide (Reglan)
Anti-emetic
MOA: bind dopamine D1/D2 receptors in chemoreceptor trigger zone
Tox: extrapyramidal side effects, sedation
Epoetin alfa
short acting RBC growth factor
- must have adequate iron stores
Tox: hypertension, rash, arthralgias
Darbepoetin
long acting RBC growth factor
- must have adequate iron stores
Filgrastim
G-CSF - myeloid growth factor for neutropenia
Tox: fever (cytokines), bone pain (marrow elements), increase in uric acid, LDH, alk phos, rash
Pegfilgrastim
G-CSF - myeloid growth factor for neutropenia
- also has PEG to double weight (decreases clearance)
Tox: fever (cytokines), bone pain (marrow elements), increase in uric acid, LDH, alk phos, rash
Alkylating agents toxicity
- Bone marrow suppression
- nausea, vomiting diarrhea, anorexia
- sterility
- amenorrhea
- 2nd malignancy
MOA of platinum compounds
binds to DNA, RNA and produces covalent crosslinks
resistance mechanisms
- increase glutathione-S-transferase
- augmented DNA repair
- altered cellular transport
- altered DNA repair mechanism
Cisplatin
Platinum alkylating agent
- highly emetogenic (use zofran and dexamethasone)
- nephrotoxic
- neurotoxic
Cisplatin nephrotoxicity
inactivation of renal brush border (rf = high plasma levels, kidney damage, hypoalbumin, female, other drugs)
- acute - decrease electrolyte, increase BUN
- chronic - reduced GFR, normal creatinine
- anemia
Prevention - hydration, hypertonic saline, mannitol (osmotic diuretic), infusions
cisplatin neurotoxicity
- axonal degeneration
- peripheral neuropathy (stocking glove, cumulative doses)
- auditory impairment
- visual disturbances
oxaliplatin
Platinum alkylating agent
- sensory neuropathy in cold
- infusion reaction
carboplatin
Platinum alkylating agent
- hypersensitivity
- nausea vomiting
- neurotoxicity
- taxane?
- no nephrotoxicity
cyclophosphamide
Nitrogen mustard alkylator
MOA: binds to nucleophiles, DNA crosslinking, inactivation of template
Extra: removed by dialysis, is a prodrug activiated in lived
cyclophosphamide toxicity
- N/V
- myelosuppressive
- cardionecrosis
ifosfamide
nitrogen mustard alkylator
- requires hepatic P450 for activation
- produces acrolein
acrolein
metabolite of cyclophosphamide and ifosfamide
urotoxic
ifosfamide toxicity
neurotoxicity
hemorrhagic cystitis
neutropenia
nephrotoxicity - ATN
treated with methylene blue
mensa
binds acrolein in the bladder, requires multiple doses
prednisone
glucocorticoid
- immunsuppressive effects
- lympholytic
flutamide
anti androgen receptor
Tox: hot flashes, gynecomastia and breast tenderness
bicalutamide
anti androgen receptor
Tox: hot flashes, gynecomastia and breast tenderness
tamoxifen
anti estrogen binder, cell cycle specific
stimulates TGF-beta which inhibits TGF alpha and IGF-1 leading to decreased proliferation
raloxifene
anti estrogen binder, cell cycle specific
stimulates TGF-beta which inhibits TGF alpha and IGF-1 leading to decreased proliferation
letrozole
aromatase inhibitor - blocks conversion of androgen to estrogen, no effects of
cotricosteroid
Tox: arthralgias, ms pain, hot flashes, LFT
anastrozole
aromatase inhibitor - blocks conversion of androgen to estrogen, no effects of corticosteriod
Tox: astheia, hot flashes, peripheral edema, arthralgias
exemestane
aromatase inhibitor - blocks conversion of androgen to estrogen, no effects of corticosteriod
Tox: hot flashes, fatigue, headache
leuprolide
LH-RH agonist - suppression of gonadotropin, results in LH/FSH decrease
Usually has short term disease flare due to short term surge
goserelin
LH-RH agonist - suppression of gonadotropin, results in LH/FSH decrease
Usually has short term disease flare due to short term surge
methotrexate
binds reversibly to DHF reductase, S phase specific - leads to no purine synthesis